GENE ONLINE|News &
Opinion
Blog

Keytruda
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Special ASCOOncology
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
Trials & Approvals ModernaCancer Vaccine
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Trials & Approvals KeytrudaLenvima
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
Trials & Approvals Keytruda
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
China Keytruda
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
Partnerships Keytruda
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
Trials & Approvals Merck
Merck Presents Positive News For Keytruda Combination in NSCLC
2022-09-13
M&A Merck
Merck Reportedly Interested in Potential $40 Billion SeaGen Buyout
2022-07-08
Manufacturing Supply Chain
How Did the Russian Invasion of Ukraine Affect Global Biopharma?
2022-03-16
Trials & Approvals Cancer
Merck Breaks Off Keytruda Combo Trial with AstraZeneca, Begins Another with Imugene
2022-03-16
Special Breast Cancer
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Trials & Approvals Keytruda
Merck’s Keytruda Bags FDA Approval for Early Kidney Cancer in Adjuvant Setting
2021-11-18
Trials & Approvals Immunotherapy
Merck’s Keytruda Shows Survival Benefit as Adjuvant Therapy in Stage II Melanoma
2021-08-09
Day 3 ASCO 2021 Roundup: Lynparza, Keytruda and Novartis’ Radioligand Therapy Take Honors in Plenary Session
2021-06-09
1 2 3
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top